Ocular Therapeutix, Inc (OCUL)

Last Three Months

20-Apr-19 -- 19-Jul-19

Time Period:

Three Months
|
Year

$669.41K Net Amount

Buy:	$669.41K	$2.51 - $4.40
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

12

0

3

+1

0

+2

2

+3

Two Year Chart

20-Jul-17 -- 19-Jul-19

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
30-May-19 4:10 PM View:	28-May-19 Market Purchase $30.12K	Goldstein Michael H. Chief Medical Officer		Ocular Therapeutix, Inc - OCUL	88% 13.69K to 25.69K	$30.12K 88%	0	$2.51	--	Show Txns Hide Txns

17-Jun-19 7:21 PM View:	14-Jun-19 Market Purchase $10.82K	Notman Donald Chief Financial Officer		Ocular Therapeutix, Inc - OCUL	12% 21.55K to 24.05K	$10.82K 12%	0	$4.33	--	Show Txns Hide Txns

17-Jun-19 7:21 PM View:	14-Jun-19 Market Purchase $19.80K	Williams Leslie J. Director		Ocular Therapeutix, Inc - OCUL	100% 0 to 4.5K	$19.80K 100%	0	$4.40	--	Show Txns Hide Txns

10-Jun-19 4:55 PM View:	07-Jun-19 Market Purchase $197.71K	Sawhney Amarpreet Chairman of the Board Director		Ocular Therapeutix, Inc - OCUL	6% 2.84M to 3.01M	$496.26K 6%	0	$2.80 - $3.02	--	Show Txns Hide Txns

10-Jun-19 4:53 PM View:	06-Jun-19 Market Purchase $112.40K	Mattessich Antony C. President & CEO Director		Ocular Therapeutix, Inc - OCUL	69% 57.9K to 97.9K	$112.40K 69%	0	$2.81	--	Show Txns Hide Txns